Activation of HAND2-FGFR signaling pathway by lncRNA HAND2-AS1 in adenomyosis†
article
OA: closed
CC0
⤵ 1 in-corpus citation
AI-generated summary
Adenomyosis involves reduced HAND2 expression and activated FGFR signaling, linked to decreased HAND2-AS1 expression and increased DNA methylation of the HAND2 promoter.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Heart and neural crest derivatives expressed transcript 2 (HAND2) is a critical mediator of progesterone action in endometrial stromal cells. Silencing of Hand2 expression in mouse uterus leads to an unopposed FGFR-mediated action that causes female mice infertility. To investigate the involvement of HAND2-FGFR signaling in pathogenesis of adenomyosis, immunohistochemistry, in situ hybridization, and quantitative real-time PCR were employed to assess gene expression in the normal endometrium, the paired eutopic endometrium and ectopic lesions obtained from women with adenomyosis. DNA methylation in the regions of HAND2 promoter and the first exon was also monitored in these samples. Our results revealed that HAND2 expression were dramatically reduced, but FGF9 expression and FGFR-ERK1/2-mediated MAPK signaling pathway were enhanced in the eutopic endometrium and ectopic lesions of patients with adenomyosis compared to the normal controls. Interestingly, expression of HAND2-AS1, a long noncoding RNA that resides adjacent to HAND2 in genome, was also reduced in adenomyosis. DNA methylation analysis revealed that the bidirectional promoter between HAND2 and HAND2-AS1, and the first exon of HAND2 gene was heavily methylated in the eutopic endometrium and the ectopic lesions of adenomyosis. To investigate the regulation of gene expression by HAND2-AS1, HAND2-AS1 expression was silenced in human endometrial stromal cells. In contrast to the downregulation of HAND2 in response to HAND2-AS1 silencing, FGF9 expression was augmented significantly. Endometrial stromal cells lacking HAND2-AS1 exhibited enhanced proliferation and migration potentials. Collectively, our studies revealed a new molecular mechanism by which HAND2-AS1 is involved in the pathogenesis of adenomyosis via modulating HAND2-FGFR-mediated signaling.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (30)
- Adenomyosis and infertility via openalex
- Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease via openalex
- Endometriosis and adenomyosis – a shared pathophysiology via openalex
- Expression of aromatase in endometiosis and its relation to clinical laboratory and surgical parameters via openalex
- Global Transcriptome Abnormalities of the Eutopic Endometrium From Women With Adenomyosis via openalex
- Pathogenesis of adenomyosis: an update on molecular mechanisms via openalex
- Pathogenesis of uterine adenomyosis: invagination or metaplasia? via openalex
- Progesterone Alleviates Endometriosis via Inhibition of Uterine Cell Proliferation, Inflammation and Angiogenesis in an Immunocompetent Mouse Model via openalex
- Progestin-induced heart and neural crest derivatives-expressed transcript 2 inhibits angiopoietin 2 via fibroblast growth factor 9 in human endometrial stromal cells via openalex
- Regulation of HAND2 Expression by LncRNA HAND2-AS1 in Ovarian Endometriosis Involving DNA Methylation via openalex
- The symptomatology of adenomyosis via openalex
- W2099868858 via openalex
- W2765864324 via openalex
- W2014612835 via openalex
- W2968547836 via openalex
- W2990458990 via openalex
- W3003586944 via openalex
- W3026122184 via openalex
- W3094320124 via openalex
- W3110220149 via openalex
- W3127277298 via openalex
- W3210890914 via openalex
- W1994439119 via openalex
- W6629069702 via openalex
- W6663104962 via openalex
- W2151052080 via openalex
- W6728658130 via openalex
- W2148392541 via openalex
- W2546360008 via openalex
- W2581612752 via openalex
Cited by (1)
Source provenance
- europepmc
- last seen: 2026-06-19T06:14:56.452680+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-06-19T06:13:24.568674+00:00
License: CC0
· commercial use OK